SZSE •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 08/21/2026 15:04
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeSZSE
Market Capitalization5,194.49 mln
Float431 mln
EPS
0.23
Overpriced
P / E
45.39
High premium
Piotroski F-Score
7
/ 9
Strong
Beneish M-Score
-2.19
Caution advised
Relative Strength
99
/ 100
Top performer
Debt / Equity
0.25
Very low leverage
Business Description
Founded in 1992 and headquartered in Beijing, China, Beijing Beilu Pharmaceutical develops, manufactures, and sells a range of medical imaging agents and oral diabetes treatments. Its imaging products include contrast agents used in MRI and CT scans, covering both gadolinium-based and iodine-based formulations. The company also produces several oral medications for managing type 2 diabetes.
